Tara M. Davidson, MD

Education

Medical School

University of Washington - Seattle

Residency

Mayo Clinic (Rochester, MN)

Fellowship

MD Anderson Cancer Center

Board Certification

• Internal Medicine

Language(s) Spoken

• English

Awards and Distinctions

• 2024-2025
  MD Anderson The Richard Theriault Humanitas Award, Oncology MD Anderson Chief Fellow, 3rd Year LBJ Oncology Fellow award

  2022
  Mayo Clinic: Outstanding Resident Achievement Award, Top 10% Senior Medical Resident Educator Award

  2000
  Timberline High School Valedictorian

  Grants
  ASCO Young Investigator Award. Maximizing Clinical Outcomes: Triple Inhibition of PD-1, CTLA-4, and LAG-3 in Metastatic Melanoma. 2024-2025
   
  MD Anderson Cancer Center Division of Cancer Medicine’s Research Training in Academic Medical Oncology T32 Fellowship. 2023-2025

Publications

• 2025
  Konecny GE*, Davidson TM*, Lebreton CL, Marsh LA, Chetram DK, Atkinson HJ, Larson MC, Oberg AL, Abdelaal N, Silverstein J, Jatoi A, Washburn A, Burton J, Dowdy S, Zhang L, Hallberg D, Velculescu VE, Slamon DJ, Wahner-Hendrickson AE. Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer. Int J Gynecol Cancer. 2025 Oct;35(10):102028. doi: 10.1016/j.ijgc.2025.102028. Epub 2025 Jul 28. PMID: 40839974. * co first authors

  2024
  Davidson TM, Hieken TJ, Glasgow AE, Habermann EB, Yan Y. Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020. Melanoma Res. 2024 Apr 1;34(2):175-181. doi: 10.1097/CMR.0000000000000953. Epub 2024 Jan 23. PMID: 38265469

  2023
  Davidson TM, Lebreton CL, Hendricksen AEW, Atkinson HJ, Larson MC, Oberg AL, Provencher DM, Glaspy JA, Karlan BY, Slamon DJ, Konecny GE, Ray-Coquard IL. Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 2023 Mar;170:221-228. doi: 10.1016/j.ygyno.2023.01.021. Epub 2023 Jan 27. PubMed PMID: 36709663.

  2023
  Davidson, T. et al. Clinical Trial Diversity: Outcomes for US patients with advanced cancer in Phase 1 clinical trials at a major cancer center. 2023 AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorites and the Medically Underserved.